Inhibiting CSF1 to deplete macrophages within tumors significantly diminishes the angiogenic potential of breast cancer and tumor burden, but restoring the expression levels of CSF1 can block TAM depletion and enhance the angiogenic potential of tumors (93, 94). This evidence concerns the gene CSF1 and breast carcinoma.